Latest Amylyx Pharmaceuticals News & Updates

See the latest news and media coverage for Amylyx. We track all announcements, press releases, and industry mentions in real time, all in one place.

Amylyx Pharmaceuticals (Amylyx)

Biopharmaceutical company developing novel therapies

amylyx.com

Headquarters: Cambridge, United States
Company type: Public company
Number of employees: 150–200

Last updated Today

Latest news about Amylyx Pharmaceuticals (Amylyx)

In short: Amylyx Pharmaceuticals advanced its late-stage pipeline for rare diseases while settling investor litigation and managing major program shifts.

Company announcements

May 15 Amylyx

Amylyx publishes positive HELIOS trial results in Wolfram syndrome

Week 24 and 48 results show improved pancreatic function and visual acuity stabilization, with favorable safety.

May 7 Amylyx

Amylyx reports Q1 2026 financial results

R&D expenses rise to $27.6M, net loss $41.3M. LUCIDITY trial enrollment complete, topline data expected Q3 2026. Cash runway into 2028.

May 5 Amylyx

Amylyx announces U.S. Expanded Access Program for avexitide

The program provides access to eligible adults with post-bariatric hypoglycemia following Roux-en-Y gastric bypass. Avexitide is in Phase 3 LUCIDITY trial with data expected Q3 2026.

March 24 Amylyx

Amylyx completes enrollment in Phase 3 LUCIDITY trial

The trial enrolled 78 participants for avexitide in post-bariatric hypoglycemia. Topline data expected in Q3 2026.

Media coverage

June 10 Yahoo Finance

Amylyx Pharmaceuticals Eyes Q3 Phase 3 Avexitide Readout as PBH Launch Plans Take Shape

Chief Executive Officer Justin Klee said the company is preparing for a key Phase 3 readout for avexitide, its lead program for post-bariatric hypoglycemia, during...

May 20 Yahoo Finance

Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 2026 Results and Pipeline Progress

We recently compiled a list of the 8 Best Small Cap Pharma Stocks to Buy Right Now. Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is among the best...

May 16 Newser

Teva Pharmaceutical (TEVA) Reports Q1 Beat, Unveils Amylyx Deal Plans

Teva Pharmaceutical Industries (NYSE: TEVA) recently surpassed market expectations in its first-quarter results, while also disclosing plans to pursue a strategic transaction with Amylyx Pharmaceuticals...

May 15 GuruFocus

Amylyx (AMLX) Releases Promising Results from HELIOS Trial

On May 15, 2026, Amylyx Pharmaceuticals AMLX announced the publication of Week 24 and Week 48 findings from the Phase 2 open-label HELIOS clinical trial...

Never miss news about Amylyx

Track Amylyx and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Amylyx competitors & trending companies

Browse news for competitors to Amylyx and other trending companies.